Shandong Haohong Biotechnology Co., Ltd. is located in the beautiful Jiangbei Water City, Shandong Liaocheng Provincial Chemical Industrial Park. Recently, a new production workshop in the Shijiazhuang Chemical Industrial Park in Hebei is about to commence operations. The company specializes in the research, development, and production of pharmaceutical intermediates. Its production base is equipped with 30 sets of reaction kettles ranging from 50 to 5000L, with an annual manufacturing capacity of 500 tons. The company has an advanced wastewater treatment system with a daily processing capacity of 1000 tons. The company focuses on developing active pharmaceutical ingredients and intermediates for anti-cancer, anti-hepatitis C, and diabetes treatment series, with an emphasis on advanced intermediates. Key products include Enzalutamide, Macitentan, Ipragliflozin, Tofacitinib, Cabozantinib, Fluoxetine Hydrochloride, and others. Guided by the principles of "pragmatism, innovation, and integrity," the company's products are exported to overseas markets such as the United States, Taiwan, and India. It has established long-term cooperative relationships with many renowned domestic and international pharmaceutical companies. The company remains committed to providing customers with high-quality products, competitive prices, and excellent service. It sincerely hopes to establish stable strategic partnerships with outstanding enterprises both domestically and internationally.